# UNI‐494 treatment improves measures of renal dysfunction and cardiac pathology in male rats receiving L‐NAME and angiotensin II

**Authors:** Fiona Jing Min Ho, Clarice Jing Rou Siow, Hayat Aljaibeji, Miao Ding, Richard N. Mitchell, Satya Medicherla, Guru Reddy, Shalabh Gupta, Gordon H. Williams, Jose R. Romero

PMC · DOI: 10.14814/phy2.70634 · Physiological Reports · 2025-10-29

## TL;DR

UNI-494 improves kidney and heart health in rats with induced disease, without affecting blood pressure.

## Contribution

UNI-494 is a novel compound shown to reduce cardiorenal damage in a preclinical model.

## Key findings

- UNI-494 reduced albuminuria and KIM-1 levels in rats with induced kidney damage.
- Cardiac injury was significantly improved with UNI-494 treatment.
- Blood pressure remained unaffected by UNI-494 administration.

## Abstract

Mitochondrial dysfunction is essential in the pathophysiology of both cardiovascular disease (CVD) and chronic kidney disease (CKD). Nicorandil, a nicotinamide nitrate derivative, has been used for years as a cardioprotective agent. It binds to sulfonylurea receptors, activating mitochondrial ATP‐sensitive potassium channels (MitoKATP) and functioning as a Nitric Oxide (NO) donor. However, its clinical use is limited by gastrointestinal complications. UNI‐494 is a novel nicotinamide ester derivative and selective MitoKATP channel activator that reverses mitochondrial dysfunction by closing the mitochondrial permeability transition pore (mPTP) and has renoprotective effects. However, its impact on preclinical models of cardiac and renal disease is unknown. Rodents given N
ω‐nitro‐L‐arginine methyl ester (L‐NAME) to suppress NO synthase and angiotensin II (AngII) show substantial cardiac and renal damage with significant increases in blood pressure. We hypothesize that mitochondrial dysfunction contributes to the pathophysiology of cardiorenal damage in the L‐NAME/AngII rat model and that UNI‐494 would improve cardiovascular and renal parameters. We studied the in vivo impact of UNI‐494 on cardiorenal damage in the L‐NAME/AngII rat model. Treatment with UNI‐494 significantly reduced L‐NAME/AngII‐induced albuminuria, KIM‐1 levels, and cardiac injury, with no significant effect on blood pressure. Our data suggest that cardiorenal damage can be prevented by treatment with UNI‐494.

## Linked entities

- **Chemicals:** Nicorandil (PubChem CID 47528), UNI-494 (PubChem CID 155128385), L-NAME (PubChem CID 39836), angiotensin II (PubChem CID 65143), Nitric Oxide (PubChem CID 145068)
- **Diseases:** cardiovascular disease (MONDO:0004995), chronic kidney disease (MONDO:0005300)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Agt (angiotensinogen) [NCBI Gene 24179] {aka ANRT, Ang, AngII, PAT}, Havcr1 (hepatitis A virus cellular receptor 1) [NCBI Gene 286934] {aka KIM-1, Kim1}
- **Diseases:** CVD (MESH:D002318), albuminuria (MESH:D000419), gastrointestinal complications (MESH:D005767), CKD (MESH:D051436), cardiac and renal damage (MESH:D007674), Mitochondrial dysfunction (MESH:D028361), cardiorenal damage (MESH:D059347), cardiac injury (MESH:D006331)
- **Chemicals:** Nicorandil (MESH:D020108), NO (MESH:D009569), UNI-494 (-), L-NAME (MESH:D019331)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12571543/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12571543/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12571543/full.md

---
Source: https://tomesphere.com/paper/PMC12571543